期刊文献+

肝硬化肝细胞癌和非肝硬化肝细胞癌患者肝癌切除术预后因素分析 被引量:11

Prognostic factors of hepatectomy in hepatocellular carcinoma patients with and without liver cirrhosis
下载PDF
导出
摘要 目的探讨影响肝硬化肝细胞癌(hepatocellular carcinoma,HCC)和非肝硬化HCC患者预后的相关因素。方法回顾性分析2008年6月至2013年6月于清流县医院和福建医科大学附属孟超肝胆医院行肝癌切除术的224例HCC患者的临床资料。根据术后病理结果分为肝硬化HCC组(HCC-C组,131例)和非肝硬化HCC组(HCC-NC组,93例)。比较两组患者术中情况(包括手术时间、术中出血量、输血率、第一肝门阻断率、肝切除范围和手术方式)和术后情况(包括围术期并发症发生率、围术期病死率),分析影响HCC患者预后的因素。结果 (1)HCC-C组患者术中出血量显著高于HCC-NC组,差异有统计学意义(z=-2.193,P=0.03)。两组患者的手术时间、输血率和肝门阻断率的差异无统计学意义(z=-15.212,P=0.835;χ~2=0.969,P=0.537;χ~2=2.236,P=0.692)。(2)HCC-C组和HCC-NC组患者围术期并发症发生率分别为30.53%(40/131)和21.50%(20/93),差异有统计学意义(χ~2=12.013,P=0.02)。其中HCC-C组和HCC-NC组患者肺部感染、腹腔感染、肝功能衰竭发生率分别为6.11%(8/131)、3.05%(4/131)、5.34%(7/131)和3.23%(3/93)、2.16%(2/93)、1.08%(1/93),差异有统计学意义(χ~2值分别为11.857、4.465、7.326,P值分别为0.04、0.02、0.03)。HCC-C组患者和HCCNC组患者围术期病死率分别为6.11%(8/131)和2.15%(2/93),差异有统计学意义(χ~2=8.352,P=0.04)。(3)多因素分析结果显示:年龄≥60岁、Child-Pugh B级、手术时间> 360分钟、输血、肝切除范围≥3段和肝硬化是影响HCC患者预后的独立危险因素(P均<0.05);ALB <38 g/L、Child-Pugh B级、输血和肝切除范围≥3段是HCC-C组患者围术期发生肝功能衰竭的独立危险因素(P均<0.05);术中出血量> 1200 ml是HCC-NC组患者围术期发生肝功能衰竭的独立危险因素(OR=15.077,95%CI:2.695~84.353,P=0.02)。结论肝硬化是影响HCC患者肝癌切除术预后的独立危险因素。HCC-C组患者出现围术期肝功能衰竭和病死的风险显著高于HCC-NC组患者。 Objective To investigate the prognostic factors of hepatectomy in hepatocellular carcinoma (HCC) patients with and without liver cirrhosis. Methods The clinical data of 224 patients with HCC underwent hepatectomy in Qingliu County Hospital and Mengchao Hepatobiliary Hospital Affiliated to Fujian Medical University from June 2008 to June 2013 were retrospectively analyzed. According to the postoperative pathological results, 131 HCC patients with liver cirrhosis were taken as HCC-C group, 93 HCC patients without liver cirrhosis were taken as HCC-NC group. The intraoperative conditions (including operative time, intraoperative bleeding volume, blood transfusion rate, first hilar occlusion rate, hepatectomy range and operation mode) and postoperative conditions (including perioperative complications, perioperative mortality) were observed and compared between the two groups. Prognostic factors in patients with HCC were analyzed. Results ①The intraoperative bleeding volume of patients in HCC-C group was significantly higher than that in HCC-NC group, the difference was statistically significant (z = -2.193, P = 0.03). There were no significant differences in operation time, blood transfusion rate and first hilar occlusion rate between the two groups (z = -15.212, P = 0.835; χ 2 = 0.969, P = 0.537; χ 2 = 2.236, P = 0.692). ②The incidence of perioperative complications in HCC-C group and HCC-NC group were 30.53% (40/131) and 21.50% (20/93), respectively. The difference was statistically significant (χ 2 = 12.013, P = 0.02). The incidence rate of pulmonary infection, abdominal infection and liver failure was 6.11% (8/131), 3.05% (4/131), 5.34% (7/131) in HCC-C group and 3.23% (3/93), 2.16% (2/93), 1.08% (1/93) in HCC-NC group, respectively, and the differences were statistically significant between the two groups (χ 2 = 11.857, 4.465, 7.326; P = 0.04, 0.02, 0.03). The mortality rate of perioperative period was 6.11% (8/131) in HCC-C group and 2.15% (2/93) in HCC-NC group, respectively, the difference was statistically significant between the two groups (χ 2 = 8.352, P = 0.04). ③Multivariate analysis results showed that ≥ 60 years old, Child- Pugh B grade, operative time ≥ 360 minutes, transfusion, extent of liver resection≥ 3 segments and liver cirrhosis were the independent risk factors of prognosis for patients with HCC (P 〈 0.05); ALB 〈 38 g/L, Child-Pugh B grade, trasnfusion and extent of liver resection ≥ 3 segments were the independent risk factors of liver failure in perioperative period for patients in HCC-C group (P 〈 0.05); blood loss 〉 1200 ml was the independent risk factor of liver failure for patients in HCC-NC group in perioperative period (OR = 15.077, 95%CI: 2.695~84.353, P = 0.02). Conclusions Liver cirrhosis is an independent risk factor for the prognosis of hepatectomy in patients with HCC. The risk of liver failure and death of patients in HCC-C group is significantly higher than that of patients in HCC-NC group.
作者 邓强 林伙明 罗顺峰 DENG Qiang;LIN Huo-ming;LUO Shun-feng(Department of Surgery I,Qingliu County Hospital of Fujian Province,Qingliu 365300,Fujian Province,China;Department of Liver Surgery,Mengchao Hepatobiliary Hospital Affiliated to Fujian Medical University,Fuzhou 350002,China)
出处 《中国肝脏病杂志(电子版)》 CAS 2018年第3期20-26,共7页 Chinese Journal of Liver Diseases:Electronic Version
关键词 肝细胞癌 肝硬化 肝癌切除术 预后 Hepatocellular carcinoma Liver cirrhosis Hepatectomy Prosnosis
  • 相关文献

参考文献4

二级参考文献51

  • 1Ai-Jun Li,Wei-Ping Zhou,Chuan Lin,Xi-Long Lang,Zhen-Guang Wang,Xiao-Yu Yang,Qing-He Tang,Ran Tao,Meng-Chao Wu.Surgical treatment of hepatocellular carcinoma with inferior vena cava tumor thrombus: a new classification for surgical guidance[J].Hepatobiliary & Pancreatic Diseases International,2013,12(3):263-269. 被引量:17
  • 2刘琳,赵伟,秦叔逵,邱少敏,李苏宜,陈惠英.三氧化二砷对人大肠癌细胞生长及其端粒酶活性的影响[J].肿瘤防治研究,2006,33(4):246-249. 被引量:5
  • 3艾志龙,秦新裕.亚砷酸在实体瘤中的研究进展[J].中国临床医学,2006,13(3):429-430. 被引量:14
  • 4马兴标,唐亨力,付留中.三氧化二砷治疗中晚期肝癌15例疗效分析[J].中国热带医学,2007,7(2):240-240. 被引量:4
  • 5中国抗癌协会肝癌专业委员会,中国抗癌协会临床肿瘤协作专业委员会,中华医学会肝病学分会肝癌学组.原发性肝癌规范化诊治的专家共识[J].肿瘤,2009,29:295-305.
  • 6Terzi E, Golfieri R, Piscaglia F, et al. Response rate and clinical outcome of HCC after first and repeated cTACE performed "on demand"[J]. J Hepatol,2012,57:1258-1267.
  • 7Shen ZX, Chen GQ, Li XS, et al. Use of arsentic trioxide (As203) in the treatment of APL: remission induction in relapsed patients and pharmacokinetics[J]. Blood,1997,89:3354-3360.
  • 8Tan B, Huang JF, Wei Q, et al. Anti-hepatoma effect of arsenic trioxide on experimental liver cancer induced by 2-acetaminddofluorene in rats[J]. World J Gastroenterol,2005,11:5938-5947.
  • 9Duffy A, Wilkerson J, Greten TF. Hemorrhagic events in hepatocellular carcinoma patients treated with anti-angiogenic therapies[J]. Hepatology, 2013,57:1068-1077.
  • 10Edwin B, Nordin A, Kazaryan AM. Laparoscopic liver surgery: new frontiers[ J]. Scand J Surg,2011,100 ( 1 ) :54-65.

共引文献39

同被引文献122

引证文献11

二级引证文献61

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部